Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Diego Zara
Observed names:
D Zară,
D. Zara,
Zara, Diego
Observed institutions:
University of Udine,
Ospedale Santa Maria della Misericordia di Udine,
Centro di Riferimento Oncologico,
Istituti di Ricovero e Cura a Carattere Scientifico,
IRCCS Humanitas Research Hospital,
Azienda sanitaria universitaria Friuli Centrale
show all 6
ORCID:
0000-0001-5321-0456
Observed ORCID:
0000-0001-5321-0456
OpenAlex ID:
A5017048152
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors
2024
·
Brigida Anna Maiorano
, Massimo Di Maio
, et al.
·
JAMA Network Open
·
50
First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study
2021
·
Debora Basile
, Lorenzo Gerratana
, et al.
·
The Breast
·
36
PDF
Liquid Biopsy in NSCLC: An Investigation with Multiple Clinical Implications
2023
·
Elisa Bertoli
, Elisa De Carlo
, et al.
·
International Journal of Molecular Sciences
·
30
PDF
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG
2020
·
Melissa Bersanelli
, Diana Giannarelli
, et al.
·
Therapeutic Advances in Medical Oncology
·
25
Multidisciplinary Team Meeting Proposal and Final Therapeutic Choice in Early Breast Cancer: Is There an Agreement?
2022
·
Lucia Bortot
, Giada Targato
, et al.
·
Frontiers in Oncology
·
8
PDF
Preoperative treatments in borderline resectable and locally advanced pancreatic cancer: Current evidence and new perspectives
2023
·
Marco de Scordilli
, Anna Michelotti
, et al.
·
Critical Reviews in Oncology/Hematology
·
7
Joint survey by AIMN, AIOM, AIRO, SIU, SIUrO, and Meet-URO about the use of PSMA PET imaging in prostate cancer in Italy: technical aspects and primary staging setting
2025
·
Matteo Bauckneht
, Laura Evangelista
, et al.
·
Clinical and Translational Imaging
·
6
PDF
Number Needed to Treat in Trials of Targeted Therapies for Advanced Ovarian Cancer
2022
·
Michele Bartoletti
, Sandro Pignata
, et al.
·
JAMA Network Open
·
6
PDF
Estimating survival in patients with melanoma brain metastases: prognostic value of lactate dehydrogenase
2023
·
Giacomo Pelizzari
, Elisa Bertoli
, et al.
·
Melanoma Research
·
4
295P Clinical characterization and outcome of a HER2-low metastatic breast cancer (mBC) cohort receiving first-line treatment (1L) with ET +/- CDK 4/6 inhibitor (CDKi)
2021
·
L. Bortot
, D. Basile
, et al.
·
Annals of Oncology
·
4
Feasibility and Predictive Performance of a Triage System for Patients with Cancer During the COVID-19 Pandemic
2021
·
Gianpiero Fasola
, Giacomo Pelizzari
, et al.
·
The Oncologist
·
4
PDF
Joint survey by AIMN, AIOM, AIRO, SIU, SIUrO, and Meet-URO about the use of PSMA PET imaging in prostate cancer in Italy: PSA persistence, biochemical recurrence, hormone-sensitive and castration-resistant metastatic settings
2026
·
Matteo Bauckneht
, Laura Evangelista
, et al.
·
Clinical and Translational Imaging
·
3
PDF
GU-CA-COVID: a clinical audit among Italian genitourinary oncologists during the first COVID-19 outbreak
2021
·
Melissa Bersanelli
, Sebastiano Buti
, et al.
·
Therapeutic Advances in Urology
·
3
1741P Triage procedures for COVID-19 in an Italian cancer centre
2020
·
G. Targato
, D. Zara
, et al.
·
Annals of Oncology
·
2
PDF
Impact of sarcopenia in patients with metastatic melanoma treated with immunotherapy
2019
·
M.G. Vitale
, D. Basile
, et al.
·
Annals of Oncology
·
2
Clinical decision making and multidisciplinary team meetings (MDMs) in early breast cancer. Is the agreement between planned and applied therapeutic program?
2019
·
M. Giavarra
, E. Bertoli
, et al.
·
Annals of Oncology
·
1
2520eP Drug–drug interactions in older patients treated with abiraterone or enzalutamide for advanced prostate cancer: Results from the ADHERE prospective study (Meet-URO Network)
2025
·
L. Fratino
, D. Zara
, et al.
·
Annals of Oncology
Metastatic renal cell carcinoma (mRCC) primary refractory patients to first-line IO-TKI and IO-IO combinations (Meet-URO 33 analysis).
2025
·
Davide Bimbatti
, Alessio Signori
, et al.
·
Journal of Clinical Oncology
1626P The perks of SARS-CoV-2 monitoring through serial nasopharyngeal (NP) swabs in an Italian high prevalence area
2021
·
L. Bortot
, M. Cinausero
, et al.
·
Annals of Oncology
PDF
1613P_PR An estimate of the 2-year oncology workload generated by each new patient: A real-world study
2020
·
S.K. Garattini
, A.M. Minisini
, et al.
·
Annals of Oncology
342P Different modalities of detection breast cancer recurrences: A 5-year retrospective cohort study
2020
·
D. Zara
, L. Palmero
, et al.
·
Annals of Oncology
Management of immune-related adverse events: A single-center retrospective analysis in a real-world scenario.
2020
·
Donatella Iacono
, Maria Grazia Vitale
, et al.
·
Journal of Clinical Oncology
Triage procedure for covid-19 in an oncology department: An Italian monocentric experience
2020
·
D Zară
, Giada Targato
, et al.
·
Tumori
A multivariate model to define prognostic groups among patients with melanoma brain metastases: A 10-year retrospective cohort study
2019
·
G. Pelizzari
, E. Bertoli
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
26
Citation count:
191
H-index:
6
I10-index:
4
Year
Topic
Type
